18F-FDG PET/CT prognostic role in predicting response to salvage therapy in relapsed/refractory Hodgkin's lymphoma

R Eisazadeh, SA Mirshahvalad - Clinical Imaging, 2022 - Elsevier
Purpose To evaluate the response predictors, both clinical and 18 F-FDG PET/CT
parameters, in Hodgkin's lymphoma (HL) patients diagnosed with refractory/relapsed …

18F-FDG PET/CT prognostic role in predicting response to salvage therapy in relapsed/refractory Hodgkin's lymphoma

R Eisazadeh, SA Mirshahvalad - Clinical Imaging, 2022 - clinicalimaging.org
Purpose To evaluate the response predictors, both clinical and 18 F-FDG PET/CT
parameters, in Hodgkin's lymphoma (HL) patients diagnosed with refractory/relapsed …

18F-FDG PET/CT prognostic role in predicting response to salvage therapy in relapsed/refractory Hodgkin's lymphoma

R Eisazadeh, SA Mirshahvalad - Clinical imaging, 2022 - pubmed.ncbi.nlm.nih.gov
Purpose To evaluate the response predictors, both clinical and 18 F-FDG PET/CT
parameters, in Hodgkin's lymphoma (HL) patients diagnosed with refractory/relapsed …

18F-FDG PET/CT prognostic role in predicting response to salvage therapy in relapsed/refractory Hodgkin's lymphoma.

R Eisazadeh, SA Mirshahvalad - Clinical Imaging, 2022 - europepmc.org
Purpose To evaluate the response predictors, both clinical and 18 F-FDG PET/CT
parameters, in Hodgkin's lymphoma (HL) patients diagnosed with refractory/relapsed …